Semaglutide is also prescribed for long-term weight management in individuals who are obese (with a body mass index of 30 or higher) or overweight (with a body mass index of 27 or higher) with at least one weight-related condition such as cardiovascular disease, high blood pressure, or type 2 diabetes
Case reports have linked GLP-1 agonists like semaglutide to an increased risk, although large studies have shown mixed results
Yang, H., Yang, X., Yan, S., & Sun, Z
Don't rush this part
As research in this area continues to progress, it holds the promise of improving the quality of life for women experiencing the challenges of hormonal changes during these life stages
Quick access to guidance is especially useful in those early weeks when the body is still adjusting to the medication